Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1
Leonie Neirich(TUM Klinikum), Sabine Grill(TUM Klinikum), Maryam Yahiaoui‐Doktor(Leipzig University), Jacqueline Lammert(German Cancer Research Center), Anika Berling-Ernst(TUM Klinikum), Christoph Engel(University Hospital Leipzig), Anne S. Quante(Helmholtz Munich), Maryam Basrai(University of Hohenheim), Benjamin Seethaler(University of Hohenheim), Martin Halle(German Centre for Cardiovascular Research), Uwe Niederberger(University Hospital Schleswig-Holstein), Marion Kiechle(Klinikum rechts der Isar), Stephan C. Bischoff(University of Hohenheim), Juliane Ramser(Klinikum rechts der Isar), Kerstin Rhiem, Rita K. Schmutzler(University of Cologne), Thorsten Schmidt(University of Tübingen)
Cited by 4
Related Papers
ESPEN guideline on clinical nutrition in the intensive care unit
|Clinical Nutrition|2018|2.8k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Intestinal permeability – a new target for disease prevention and therapy
|BMC Gastroenterology|2014|1.7k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k